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The importance of active learning and practice
on the students' mastery of pharmacokinetic
calculations for the intermittent intravenous
infusion dosing of antibiotics
Reza Mehvar
Abstract
Background: Estimation of pharmacokinetic parameters after intermittent intravenous infusion (III) of antibiotics,
such as aminoglycosides or vancomycin, has traditionally been a difficult subject for students in clinical
pharmacology or pharmacokinetic courses. Additionally, samples taken at different intervals during repeated dose
therapy require manipulation of sampling times before accurate calculation of the patient-specific pharmacokinetic
parameters. The main goal of this study was to evaluate the effectiveness of active learning tools and practice
opportunities on the ability of students to estimate pharmacokinetic parameters from the plasma samples obtained
at different intervals following intermittent intravenous infusion.
Methods: An extensive reading note, with examples, and a problem case, based on a patient’s chart data, were
created and made available to students before the class session. Students were required to work through the case
before attending the class. The class session was devoted to the discussion of the case requiring active
participation of the students using a random participation program. After the class, students were given additional
opportunities to practice the calculations, using online modules developed by the instructor, before submitting an
online assignment.
Results: The performance of students significantly (P < 0.001) improved from a baseline of 11.3% (pretest) to
60.3% (posttest) after the class discussion. The grades of students further improved (P < 0.001) to 89.3% on
the take-home assignment after they had a chance to study on their own and work on the online practices. Finally,
students scored 82.6% in a formal mid-term examination, suggesting significant retention of the materials.
Conclusions: Despite being a difficult subject, students achieve mastery of pharmacokinetic calculations for the
topic of intermittent intravenous infusion when appropriate active learning strategies and practice opportunities are
employed.
Keywords: Active learning, Practice opportunities, Evaluation of performance, Pharmacokinetics, Elimination rate
constant, Half life, Volume of distribution
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Background
Intermittent intravenous infusion (III) is a mode of drug
administration whereby the drug is administered through
short intravenous infusions at regular intervals. This
method of drug administration may be useful for avoiding
dangerously high concentrations that may be achieved by
intravenous bolus administration. Additionally, the short
infusion time masks the distribution phase, therefore min-
imizing problems associated with the interpretations of
the plasma concentration-time data for drugs that follow
multicompartment kinetics.
Important drugs that are administered by the III
method are aminoglycosides and vancomycin, which are
usually administered by 30–60 min short infusions [1,2].
The initial dose and dosing interval of these drugs are
normally determined based on population pharmacoki-
netic parameters adjusted for the patient’s characteris-
tics, such as creatinine clearance and weight. After the
administration of the initial dose, however, drug concen-
trations are determined in serum samples taken from the
patient, and the dosage regimen is adjusted, if necessary.
Usually, two samples (peak and trough) are taken after
the first dose or at steady state for determination of drug
concentrations. For aminoglycosides, the common sam-
pling times for the peak are 30 min after a 30-min infu-
sion or 15 min after a 60-min infusion. Regardless of the
length of infusion, it is recommended that the peak sam-
ple be taken ≥ 1 h after the start of infusion to avoid the
distribution phase [3]. The second (trough) sample is
normally taken ≤ 30 min before the next dose is admi-
nistered. In some cases, the trough is taken immediately
before the next infusion is administered. The serum
drug concentrations are then used for the estimation of
patient-specific kinetic parameters.
There are subtle differences between the III and mul-
tiple bolus dosing of drugs in terms of estimation of some
pharmacokinetic parameters such as maximum plasma
concentration (Cmax) and volume of distribution (V). The
main reason for these differences is a relatively signifi-
cant elimination of the drug during the drug input (short
infusion) for the III mode, as opposed to a negligible
elimination of the drug during the bolus input. Conse-
quently, the Cmax after III, which occurs at the end of
the short infusion, is always less than the maximum con-
centration after the intravenous bolus dosing (Co), which
occurs immediately after the bolus dose (Figure 1).
Therefore, the estimation of Cmax and calculation of
volume of distribution after III are more complicated
than those after the intravenous bolus dosing.
Additionally, a common practice for sampling at steady
state for drugs administered through III is to obtain the
peak and trough samples from two subsequent dosage
intervals: a trough sample is taken first, followed by the
infusion of the next dose and collection of the peak
sample [3]. This method is more convenient and exped-
itious relative to obtaining a peak and a trough sample
from the same interval, which requires longer time for
collection of both samples. The collection of the peak
and trough samples from two different dosage intervals,
however, requires manipulation of sampling times before
accurate calculation of the patient-specific kinetic para-
meters. At Texas Tech School of Pharmacy, the principles
of these calculations have traditionally been discussed in
different didactic courses taught to Doctor of Pharmacy
(Pharm.D.) students. However, opportunities to practice
these principles before their application during the
Advanced Pharmacy Practice Experience rotations have
been limited. Therefore, new learning tools were created
for inclusion into a basic pharmacokinetics course to allow
students to learn how to estimate the patient-specific
kinetic parameters from the simulated patient chart data,
with a particular emphasis on the use of the peak and
trough samples from two different dosage intervals at
steady state. The purpose of this article is to present
these tools and the assessment of their effectiveness.
Methods
Educational context
Basic Pharmacokinetics is a 3-semester-credit-hour course
that is offered synchronously, using videoconferencing
technology, to the local (Amarillo) and distant (Abilene)
campuses twice a week with 75 min of instruction time
for each session. Although most of the instructions initi-
ate from the Amarillo campus, where the author resides,
a second instructor is located in Abilene to assist the
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Figure 1 Plasma/serum concentration-time profiles of a drug
administered by intermittent intravenous infusion or
intravenous bolus method. Solid and dashed lines represent the
intermittent intravenous infusion and intravenous bolus methods,
respectively. Abbreviations: Co = maximum concentration after the
bolus dose; Cmax =maximum concentration after the short infusion;
tinf = length of short infusion; Cmin =minimum concentration.
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students inside and outside the classroom. The course is
offered during the second year (P2) of a 4-year Pharm.D.
program and runs throughout the fall semester with
16 weeks of instruction, excluding holidays. The pre-
requisites for the course are P2 academic standing
and successful completion of a Principles of Drug Action
course that is offered during the spring semester of the
first year. The teaching format of the course is based on
the active learning principles applicable to large class-
rooms, as described in more detail in the following sec-
tions. For the fall of 2011, the class had a total enrolment
of 152 students, with 114 students on the Amarillo cam-
pus and 38 students on the Abilene campus.
The overall outcomes of the course are presented in
Table 1. Outcome 3 (Table 1) deals with the estimation
of patient-specific pharmacokinetic parameters after any
route of administration using a limited number of sam-
ples. To achieve this outcome for the III mode of drug
administration, a 75-min session and various instruc-
tional tools were designed and devoted to this topic. The
major outcome and learning objectives for this session
are presented in Table 2. The session is scheduled around
the middle of the semester after coverage of the pharma-
cokinetics of single oral and intravenous doses, constant
intravenous infusion, and multiple bolus intravenous or
oral doses. Therefore, students already have ample op-
portunity to practice estimation of the rate constant and
half life using the data from the same interval after the
first dose or at steady state. However, the concept of esti-
mation of the elimination rate constant from a peak and
trough belonging to two separate intervals is introduced
for the first time during the III session. Other new
concepts introduced during this session are the estima-
tions of Cmax, which occurs at the end of short infu-
sion (Figure 1), the time difference between the Cmax
and Cmin, which is less than one dosage interval, and the
estimation of V using newly-introduced equations based
on the Sawchuk-Zaske method [4]. Additionally, simu-
lated chart data for the times of dosing and sampling are
used for the first time in this session.
To achieve the stated outcome and learning objectives
(Table 2), the following learning tools were used for this
session: reading notes, a practice problem for use during
the class session, and an online, take-home assignment
with multiple opportunities to practice. These tools are
described in the following sections.
Descriptions of the major elements of the reading notea
A reading handout was prepared by the instructor, which
was made available to students online via the course
website. The reading note starts with the expected out-
comes and learning objectives for the lesson (Table 2),
followed by the potential applications of the III method
(i.e., avoidance of high concentrations and masking of
the distribution phase). Next, the potential differences
between the peak and Cmax and between the trough and
Cmin are explained (Figure 1), and the students are
cautioned not to use these terms interchangeably. The
remainder of the note is devoted to the estimation of the
kinetic parameters based on the Sawchuk-Zaske method
[4], with specific examples.
Table 1 Major outcomes for the pharmacokinetics course
1. Evaluate the primary and secondary drug information
literature with regard to the pharmacokinetics and
pharmacodynamics of drugs.
2. Evaluate the basic pharmacokinetics and pharmacodynamic
properties of a drug and relate them to the manner in
which the drug is used therapeutically.
3. Estimate patient-specific kinetic parameters for any drug
and route of administration from a limited number
of biological samples.
4. Design dosage regimens based on the patient-specific
or population (average) pharmacokinetic/ pharmacodynamic
data.
5. Predict the effects of route and/or method of drug
administration on the plasma concentration-time profiles
using the individual or population (average) kinetic data
and judge the appropriateness of dosage form and route
of administration.
6. Predict the effects of changes in the physiological parameters
(due to drug interactions, disease states, or special populations)
on the pharmacokinetics and plasma concentration-time
profile of drugs, and recommend a dosage regimen based
on the altered parameters.
Table 2 Major outcome and learning objectives for the
intermittent intravenous infusion session
1. Expected outcome:
1.1 Estimate major kinetic parameters (elimination rate
constant or half life, volume of distribution, and clearance)
from two or more plasma concentration-time data collected
after intermittent intravenous infusion of drugs during the
first dose or at steady state.
2. Learning objectives:
2.1 Define the applications of intermittent intravenous
infusion method.
2.2 Recognize the differences between the maximum and
peak and between the minimum and trough concentrations.
2.3 Estimate the elimination rate constant and half life from
the peak and trough concentrations after the first dose.
2.4 Estimate elimination rate constant and half life from a trough
concentration collected at the end of one dosage interval
and a peak concentration collected subsequently after the
infusion of the next dose at steady state.
2.5 Estimate the maximum and minimum concentrations from
the peak or trough concentrations and elimination rate
constant for the first dose or at steady state.
2.6 Estimate volume of distribution after the first dose or at
steady state.
2.7 Estimate clearance after the first dose or at steady state.
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Estimation of the elimination rate constant (k) and half
life (t1/2)
First, the simple situation when the peak and trough
samples are taken from the same interval is discussed.
For this method, the calculation of k is based on the fol-
lowing equation:
k ¼
1n C1C2
 
T2  T1 ¼
1n CpeakCtrough
 
Ttrough  Tpeak ð1Þ
where Ttrough and Tpeak are the sampling time of peak
and trough, respectively. Subsequently, t1/2 may be
obtained using k:
t1=2 ¼ 0:693k ð2Þ
Additionally, a major emphasis is made on the estima-
tion of k and t1/2 for a case when the trough and peak
samples are taken from two different dosage intervals at
steady state. In these cases, a trough is first taken around
the end of an interval, followed by the administration of
the next dose and collection of the peak sample. This is
usually done for the sake of convenience and/or expedi-
ency. Otherwise, one may have to wait close to one dosage
interval to collect both the peak and trough samples from
the same dosage interval. An example of data (Figures 2A)
obtained from two dosage intervals at steady state
(excerpts from the patient’s chart) is presented in the
notes. It is obvious that a direct use of the time data
given for the peak and trough samples (Figure 2A) in
equation (1) would result in an incorrect estimation of k.
Several solutions for manipulation of time data are then
presented to students as demonstrated in Figure 2B.
One method is to transform the time of trough or peak.
At steady state, the peak and trough concentrations are
supposed to be the same for all the dosage intervals, as
demonstrated in Figure 3 for an example drug. As shown
in Figure 3A, the trough concentration (1.37 mg/L)
taken during the 4th interval is the same as that if it had
been taken at the same time within the 5th interval
(Figure 3A). Therefore, one may assume that the trough
sample taken after the 4th dose is indeed the trough
sample after the 5th dose, the same interval that the peak
was taken. Consequently, the Ttrough (1500) has to be
extended by one dosage interval (8 h) before substitution
in equation (1) (Figures 2B and 3A).
Similarly, the peak concentration taken 0.5 h after the
infusion is stopped (4.68 mg/L) after the 5th dose is the
same as that if it had been taken 0.5 h after the com-
pletion of the 4th dose (Figure 3A). Therefore, as an alter-
native to moving the trough time forward, Tpeak (1630)
may be moved back by one dosage interval (8 h) to the
interval when the trough was taken (Figures 2B and 3A)
before substitution in equation (1).
Another method for the estimation of Ttrough and Tpeak
for substitution in equation (1) is to use the sampling
time relative to the beginning of the dosing interval in
which the sample is taken. In the example here
(Figures 2B and 3B), the beginning of dosage interval for
the sample taken at 1500 is 0730. Therefore, Ttrough is
7.5 h (15–7.5). Similarly, the beginning of dosage interval
for the sample taken at 1630 is 1530, hence resulting in
a Tpeak value of 1.0 h (16.5-15.5) (Figures 2B and 3B).
Substitution of these values in equation (1) results in the
Excerpts from Medication Administration Record:
Gentamicin 80 mg Q8H 
IV Infusion over 30 min 
Start 10/13/11  0730  1530  2330 
Excerpts from Laboratory Report: 
Manipulation of Trough or Peak Time:
Gentamicin Serum Concentration  
Date 10/14/11 10/14/11 
Time 1500 1630 
Concentration (mg/L) 1.37 4.68 
Moving the Trough One Interval Forward 
Date 10/14/11 10/14/11 
Time 2300 (1500+8) 1630 
Concentration (mg/L) 1.37 4.68 
Moving the Peak One Interval Backward 
Date 10/14/11 10/14/11 
Time 1500 0830 (1630–8) 
Concentration (mg/L) 1.37 4.68 
Calculating the Time within the Interval 
11/41/0111/41/01etaD
03610051emiT
Beginning of Interval 0730 1530 
Time within the Interval 7.5 1 
Concentration (mg/L) 1.37 4.68 
A 
B 
Figure 2 Chart data. Excerpts from a patient’s chart data
containing the medication administration record and laboratory
(plasma concentration-time) data after administration of multiple
doses of gentamicin to a patient (A) and manipulation of sampling
time of trough or peak or calculation of sampling time within the
interval for use in equation (1) (B).
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same k as with the other methods, which transformed
the clock time of the peak or trough samples.
Estimation of Cmax and Cmin
In addition to the estimation of k and t1/2, the note also
discusses, with examples, the estimation of Cmax and
Cmin for any dosage interval (e.g., before and at steady
state) using the following general equation:
C2 ¼ C1ek t2t1ð Þ ð3Þ
This equation can be used for the estimation of drug
concentration at any time when another concentration-
time data (peak or trough) and k are known. One must
assure, however, that C2 is the lower concentration (at
the later time of t2) and C1 is the higher concentration
(at the earlier time of t1). If the estimated Cmax and Cmin
are after the first dose, they may be multiplied by the
accumulation factor to predict their corresponding values
at steady state.
Estimation of volume of distribution
The notes also discuss the estimation of V for the first
dose, steady state, and dosage intervals between the first
dose and steady state using equations (4), (5), and (6),
respectively, which are derived based on the Sawchuck-
Zaske method [4]:
V ¼ R0
k
 1 e
kt inf 
Cmax
ð4Þ
V ¼ R0
k  C1max
 1 e
kt inf 
1 ekτð Þ ð5Þ
V ¼ R0
k
 1 e
kt inf
 
Cmax  Cpredoseekt inf ð6Þ
where Ro, tinf, τ, Cmax
∞ , and Cpredose are the rate of infu-
sion, length of infusion, Cmax at steady state, and predose
Cmin, respectively. Additionally, the degree of error asso-
ciated with the estimation of V using the bolus dose
equations (7) (for the first does) and (8) (for the steady
state), listed below, are discussed in the notes with nu-
merical examples [5].
V ≈
Dose
Cmax
ð7Þ
V ≈
Dose
C1max  C1min
ð8Þ
The notes state that the degree of overestimation of
V using the equations for the bolus route is dependent
on the magnitude of difference between Co (if the drug
were administered by IV bolus route) and Cmax.
This means the longer the length of the infusion or the
faster the decline in the plasma concentration (shorter
half life), the larger is the difference between the Co
and Cmax values, hence resulting in a higher over-
estimation of V [5].
0.1 
1 
10 
Co
nc
. (m
g/L
) 
0730        1530   2330    0730     1530      2330
10/13 10/14 
  First Dose    Second Dose   Third Dose    Fourth Dose    Fifth Dose 
1 
10 
Co
nc
. (m
g/L
) Fourth Dose                      Fifth Dose 
0730                                    1530                                                2330
10/14 
Ttrough (7.5 hr) 1500
1630
Tpeak (1.0 hr) 
A 
B 
Figure 3 Serum/plasma concentration-time Profiles. Serum/plasma concentration-time course of gentamicin after intermittent intravenous
infusion in a patient after intravenous infusion of 80 mg of the drug over 30 min every 8 h, demonstrating the manipulation of peak or trough
time (A) and calculation of sampling time for peak (Tpeak) and trough (Ttrough) within the interval (B). Solid triangles: peak and trough after the
first dose; solid circles: peak and trough at steady state; dotted open circles: transposed peak or trough at steady state.
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Estimation of clearance (Cl)
The discussion of the estimation of Cl for this topic in
the notes is limited because this calculation (multiplying
k by V) is not unique to this route of administration.
Practice problem for in-class discussionb
A practice problem was designed to cover the learning
objectives of the lesson (Table 2). The practice problem
consisted of two sections, one dealing with the data for
the first dose and the other with the steady-state for an
antibiotic. For the first dose data, the peak and trough
samples obtained after the first dose were presented. For
the steady-state data, a trough and peak from two subse-
quent doses were presented. In both cases, the dose,
dosage interval, and start date and times of dosing were
described. The students were then asked to estimate the
kinetic parameters listed in Table 3 using the presented
data. Additionally, they were asked to compare the kin-
etic parameters (k, V, and Cl) obtained after the first dose
and at steady state, which are supposed to be similar.
As with any other topic in the course, students were
expected to work on the practice problem, consulting
the reading note, before attending the class session.
Class session
During the first 10–15 min of the class session, the in-
structor briefly outlined the general concepts of the
intermittent intravenous infusion and its potential appli-
cations. The remaining time of the session was then
devoted to the discussion of the practice problem. The
discussion was conducted by calling on students ran-
domly, using an online registration process described
previously [6], to answer each question in the practice
problem.
Online homework assignment
An online, interactive module was designed with a struc-
ture identical to the in-class practice problem using a
system described before [7]. Briefly, the online module
would create assignments by randomly selecting the kin-
etic parameters and the dosing regimen data from a
range that is preset by the instructor. Therefore, each
student would have his/her own individualized assign-
ment with unique data. The program also allows stu-
dents to generate unlimited online practices, each with a
unique set of data, accompanied by the answers to the
questions so that they can practice before submitting
their answers to the assignment questions. The students
then enter their answers to each question online and
receive immediate feedback in the form of the correct
answer and grade for that question before they enter
the next answer. The assignment was due by the mid-
night of the day the class session was conducted.
Assessment
To assess the effectiveness of the tools used to achieve
the learning objectives of the session, an online pretest
was given to students at the end of the class for the mul-
tiple dosing session, which was two days before the ses-
sion on the III topic. The students did not have access
to the notes, practice problem, or the online assignment/
practice modules before the pretest. The pretest pre-
sented dosage regimen and peak and trough data for the
steady state using the simulated chart data for a case
when the trough sample was obtained before the next
dose peak sample (similar to the data in Figure 2A).
The students were then asked to estimate 4 parameters:
k, Cmax, Cmin, and V. Similar to the online assignments,
the pretest for each student had individual, unique data.
The students were given 15 minutes to answer the ques-
tions. After the pretest, notes, practice problem, and the
online assignment/practice modules were made available
to students. Two days after the pretest, the III topic was
presented to students in a class session, and a posttest
was administered at the end of the session using the
same questions used in the pretest but with different data
set. Again, students were allowed 15 min to complete the
test online. In addition to the pre- and posttest, the stu-
dent grades on the homework assignment for the same
questions were compiled. Finally, the grades of the stu-
dents for the same 4 questions in the mid-term examin-
ation, which was administered 3 weeks after the session,
was compiled.
A one-way ANOVA with repeated measures (4 assess-
ments), followed by post-hoc Tukey’s multiple compari-
son, was used to test the differences between the total
grades of all students in different assessments. Addition-
ally, to test the effect of location (Abilene and Amarillo)
on the performance of students in the 4 assessments, the
grades were separated based on the campus. A two-way
ANOVA with repeated measures, followed by Bonferroni
post-hoc tests, was then used for the statistical analysis
of data.
Table 3 Questions in the intermittent intravenous
infusion practice problem
Questions for the first dose
data
Questions for the steady-state
data
1. Elimination rate constant
and half life
1. Elimination rate constant and
half life
2. Cmax for the first dose 2. Cmax at steady state
3. Cmin for the first dose 3. Cmin at steady state
4. Cmax at steady state 4. Volume of distribution
5. Cmin at steady state 5. Clearance
6. Volume of distribution
7. Clearance
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The study was approved by the Institutional Review
Board of Texas Tech University Health Sciences Center
under the exempt status (IRB#: A11-3674).
Results
A total of 126 students (34 from Abilene and 92 from
Amarillo) completed all 4 assessments, and therefore,
were included in the analysis. As demonstrated in
Figure 4A, the average grade of students in the pretest
was very low (11.3%). However, there was a substantial
and significant (P < 0.001) increase in the grades at the
end of the III session, as demonstrated by an average
grade of 60.3% in the posttest (Figure 4A). Compared
with the posttest, the average grades of students further
increased (P < 0.001) to 89.3% when students submitted
their take-home assignment. The average grade in the
mid-term exam, although slightly, but not statistically,
lower than those in the assignment, was significantly
(P < 0.001) higher than that in the pre- and posttest
(Figure 4A). The two-way ANOVA analysis indicated
that the performance of the students on the Abilene
campus was not significantly different from that of the
students on the Amarillo campus (P = 0.163) (Figure 4B).
Additionally, there were not any significant interactions
between the campus location and assessment perform-
ance (P = 0.443). Therefore, the differences in the grades
of students among the 4 assessments for the Abilene and
Amarillo students (Figure 4B) were similar to those for
the entire class (Figure 4A).
The percentages of students who answered each of
the questions related to k, Cmax, Cmin, and V correctly
in the 4 assessments are shown in Figure 5. The pairwise
comparisons between the assessments were tested using
Fisher’s exact test after detection of a significant effect
(P < 0.0001) of the assessments on the performance using
Chi-square analysis. For k, the number of students with
the correct answer increased progressively (P < 0.0001)
from the pretest to the posttest and then to the take-
home assignment. However, there was no significant dif-
ference (P =1.000) between the assignment and the exam
(Figure 5). Similar observations were also made for the
Cmin question (Figure 5). However, for the Cmax and
V questions, although the performance of the students
in the pretest, posttest, and assignments progressively
improved, the number of students answering the ques-
tions correctly in the mid-term exam was significantly
lower than that in the take-home assignment for these
two questions (Figure 5).
As for the use of online practices, an overwhelming
majority of students (88.1%) generated one or more prac-
tices before the submission of the online assignment, as
opposed to only 11.9% of the students who did not gen-
erate any practices. Of those who generated practices,
55.5%, 19.0%, and 7.1% generated one, two, or three
practices, respectively. The remaining students (6.3%)
generated ≥ 4 practices. The linear regression analysis of
the assignment grades against the number of generated
practices for students who generated 0–3 practices (94%
of students) are presented in Figure 6. As demonstrated
in this figure, there was a significant (P < 0.05) positive
relationship between the number of generated practices
and the assignment grade. The slope of the regression
line was 2.5%, indicating that on average every additional
practice resulted in a 2.5% increase in the students’
grades within the practice range of 0–3.
Discussion
The main goal of the instructor for the III session was
to design learning tools for students so that they learn
how to estimate major patient-specific pharmacokinetic
parameters after this route of administration. To accom-
modate the requirements of some Advanced Pharmacy
Practice Experience rotations that students be able to
estimate the kinetic parameters using the patient chart
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Figure 4 Performance data for the entire assessments. Grades
of students in Pretest, Posttest, Assignment, and Examination for the
entire class (n = 126) (A) and Abilene (n = 34) and Amarillo (n = 92)
students separately (B). Columns and bars represent mean and SEM,
respectively. *** P < 0.001.
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data and plasma concentrations taken from two intervals,
learning tools were designed with special emphasis on
these requirements. The performance data presented in
Figures 4 and 5 suggest successful achievement of this
goal using the instructional tools developed for this topic.
The students’ use of the reading notes and the practice
problem on their own before attending the class com-
bined with the activities during the class session resulted
in a significant improvement in the performance of the
students, which was demonstrated by a substantial im-
provement (P < 0.001) in the posttest grades (60%), com-
pared with the pretest grades (11%). This suggests the
effectiveness of the reading notes, practice problem, and
classroom activities. Additionally, a significant improve-
ment in the students’ performance in the take-home as-
signment (89%), compared with the posttest (60%),
suggests the effectiveness of the designed take-home
assignment with the immediate feedback and unlimited
opportunity to practice.
It could be argued that the students’ performance in
the take-home assignment is inflated relative to the other
tests because of two main differences between the assign-
ment and other tests. First, other than a due date and
time, the assignment lacked the time stress present for
the other tests. Therefore, students could spend as much
time as they needed for each question while answering
the assignment questions. Second, whereas the pretest,
posttest, and mid-term exam were not open book (except
for provision of an equation sheet), students had access
to all course materials for the take-home assignment.
Therefore, one might expect that the performance of the
students in the mid-term exam to be lower than that in
the assignment. Although the grades of students in the
mid-term exam (83%) were lower than those in the as-
signment (89%), this difference did not reach statistical
significance (Figure 4A). Nevertheless, the significant
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Figure 6 Effects of online practice generation on the online
assignment grade. Grades of students in the online assignment as
a function of the number of online practices generated before the
submission of the assignment. The percentages of students who
generated zero, one, two, or three practices were 11.9%, 55.5%,
19.0%, and 7.1%, respectively. Symbols and bars represent mean and
SEM, respectively.
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Figure 5 Performance data for the individual questions. Percentages of students who answered each of the four questions correctly in
Pretest, Posttest, Assignment, and Examination (n = 126). Abbreviations: k = elimination rate constant; Cmax =maximum concentration;
Cmin =minimum concentration; V = volume of distribution.
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improvement in the grades between the posttest and
mid-term exam (Figure 4A) indicates that the events be-
tween the two assessments, including the students’ work
on the assignment, improved students’ learning of the
subject.
At Texas Tech School of Pharmacy, the courses
offered during the first and second year of the pharmacy
curriculum are delivered synchronously to Amarillo and
Abilene campuses. The instruction may be initiated from
either campus depending on the location of the instructor.
For the Pharmacokinetics course, all the sessions initiated
from Amarillo. Therefore, the Abilene campus was
considered the distant campus. To assure equality of per-
formance between the two campuses, all the perform-
ance data were routinely monitored separately for the
two campuses. As shown in Figure 4B, there were no sig-
nificant differences between the two campuses in terms
of performance in the tests, and the performance data for
each site mirrored that for the whole class (Figure 4A).
The performance data on the individual questions
(Figure 5) were surprising. Although students had ample
opportunity to calculate k or half life using the data from
the same interval and were familiar with the concept of
repeating peak and trough values at steady state, only
4.8% of them were able to calculate k correctly in the
pretest using the data from two intervals. Despite this
very low performance in the pretest, the educational
activities designed in this course resulted in an astonish-
ing 93% correct answer in the take-home assignment
(Figure 5). Interestingly, this high level of performance
was retained even under the time-sensitive and non-open
book environment of the mid-term exam, when students
scored 92% for answering k correctly (Figure 5). This
data clearly show the importance of practice in learning
pharmacokinetic calculations or concepts. If we, as
instructors, would like students know how to estimate a
k value based on a peak and trough from two separate
intervals, we must create opportunities for them to prac-
tice this method before assessing them. Nevertheless,
the data in Figure 5 clearly show that having utilized the
learning tools described here, a large number of students
(>92%) are capable of estimating k using samples from
two intervals under the time-sensitive and stressful con-
ditions of formal examinations.
Although the trend for the Cmin data was similar to
that for k in that the performances of students in the
take-home assignment and mid-term exam were similar,
the number of students who answered the Cmax or V
questions correctly in the mid-term exam was signifi-
cantly lower than that in the take-home assignment
(Figure 5). Indeed, the lowest performance during the
mid-term exam belonged to the V question as 70% of
students answered this question correctly. This is most
likely related to the complexity of the equations for the
estimation of V. Therefore, manual calculation of V using
the complicated equations (5) or (6) under time-sensitive
conditions, such as formal exams, is associated with
more error than estimation of other parameters, which
use simpler equations.
Conclusions
In conclusion, learning tools used in a basic pharmaco-
kinetics course offered to second-year pharmacy stu-
dents are presented here for the topic of intermittent
intravenous infusion. In addition to the estimation of
pharmacokinetic parameters from the plasma concentra-
tions obtained during one interval, emphasis was placed
on a unique case when peak and trough are obtained
from two separate dosage intervals at steady state. Add-
itionally, simulated chart data were used to present the
dosing schedules and laboratory data. Although students
were familiar with the estimation of elimination rate
constant before the introduction of the intermittent
intravenous infusion topic, >95% of them could not esti-
mate the elimination rate constant accurately when the
peak and trough samples were from two separate inter-
vals. Active learning exercises and practice opportunities
employed for this topic substantially facilitated students’
mastery of these calculations, as evidenced by perform-
ance data.
Endnotes
aA complete copy of the reading note is available from
the author by request.
bA complete copy of the practice problem is available
from the author upon request.
Competing interests
The author reports no competing interest.
Authors' contributions
RM designed and carried the study, analyzed the data, and wrote the
manuscript.
Authors’ information
RM, PharmD, PhD, is a Professor of Pharmaceutical Sciences who has taught
basic and clinical pharmacokinetics courses to pharmacy students for over
25 years. He has developed numerous active learning strategies for teaching
pharmacokinetics, for which he has received several awards including
Innovation in Teaching Award from the American Association of Colleges of
Pharmacy and President’s and Chancellor’s Awards in Teaching from the
Texas Tech University Health Sciences Center.
Received: 2 May 2012 Accepted: 12 November 2012
Published: 22 November 2012
References
1. Korner B: Gentamicin therapy administered by intermittent intravenous
injections. Acta Pathol Microbiol Scand B Microbiol Immunol 1973,
Suppl 241:15–22.
2. Cunha BA, Ristuccia AM: Clinical usefulness of vancomycin. Clin Pharm
1983, 2(5):417–424.
3. Winter ME: Aminoglycoside antibiotics. In Basic Clinical Pharmacokinetics.
5th edition. Edited by Winter ME. Philadelphia, PA: Lippincott Williams &
Wilkins; 2010:134–181.
Mehvar BMC Medical Education 2012, 12:116 Page 9 of 10
http://www.biomedcentral.com/1472-6920/12/116
4. Sawchuk RJ, Zaske DE: Pharmokinetics of dosing regimens which utilize
mutiple intravenous infusions: gentamicin in burn patients.
J Pharmacokinet Biopharm 1976, 4(2):183–195.
5. Mehvar R: Confounding issues in estimation of patient-specific
pharmacokinetic parameters and dosage individualization of
aminoglycosides. Curr Clin Pharmacol 2012, 7(1):28–35.
6. Mehvar R: A participation requirement to engage students in a
pharmacokinetics course synchronously taught at a local and distant
campus. Am J Pharm Educ 2010, 74(7):118.
7. Mehvar R: On-line, individualized, and interactive pharmacokinetic
scenarios with immediate grading and feedback and potential for use
by multiple instructors. Am J Pharm Educ 1999, 63:348–353.
doi:10.1186/1472-6920-12-116
Cite this article as: Mehvar: The importance of active learning and
practice on the students' mastery of pharmacokinetic calculations for
the intermittent intravenous infusion dosing of antibiotics. BMC Medical
Education 2012 12:116.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mehvar BMC Medical Education 2012, 12:116 Page 10 of 10
http://www.biomedcentral.com/1472-6920/12/116
